Find a Pharmacy
Vertice Login
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Search Results for 已驗證的CTAL-TTA_Syll19_4.0 考題資源和資格考試領導者和可靠的CTAL-TTA_Syll19_4.0:ISTQB Certified Tester Advanced Level - Technical Test Analyst (V4.0) 🌸 《 www.newdumpspdf.com 》是獲取⮆ CTAL-TTA_Syll19_4.0 ⮄免費下載的最佳網站CTAL-TTA_Syll19_4.0熱門認證

632 posts found

FDA Approves Second OTC Naloxone Nasal Spray for Opioid Overdose

...Opioid pain medications are commonly used in workers’ comp, and even when used responsibly, opioids come with various risks, including potential overdose. Certain high-dose opioids are sometimes co-prescribed with naloxone...
Read More

The Opioid Crisis: Our Defining Moment

...out there suffering from the impacts of opioids, at the individual, family, and community levels. For every one person who dies from opioid overdose, 50 more individuals have an opioid...
Read More

FDA Approves Diazepam Nasal Spray and Fast Tracks New Drug for Spinal Cord Injury

...placebo-controlled, repeat dose study in chronic cervical spinal cord injury. Up to 24 patients will randomly receive AXER-204 or placebo, with dose level and dose frequency dependent on outcomes from...
Read More

Removing Barriers to Recovery: A Primer on Psychosocial Treatments for Injured Workers

...also affect the course of a claim and cost. When it comes to claim complexity, the number one concern for workers’ comp stakeholders is mental health conditions. What’s more, costs...
Read More

Minnesota Releases PTSD Report

At over 200 pages, this comprehensive report includes a review of PTSD claims in the workers’ comp system....
Read More

Build Your Army: Maintaining Cybersecurity Amid the IT Talent Gap

...Research also shows that cybersecurity demand is twice as great as supply. The problem is compounded for workers’ comp organizations, which are highly valuable cyber targets due to the large...
Read More

New Opioid Prescribing and Abuse Data

...importance as opioids continue to have a place in the management of workers’ comp claims. On September 19th, the National Council on Compensation Insurance (NCCI) hosted a webinar reviewing opioid...
Read More

Connecticut, Nebraska, Nevada, and Texas Introduce AI Regulation Bills

...and evolving AI regulations at the state and federal level remains an ongoing process. Connecticut Senate Bill 10 would ban health carriers from using AI or any algorithm for clinical...
Read More

FDA and CDC Recommend Resuming Use of Johnson & Johnson COVID-19 Vaccine

...women is cerebral venous sinus thrombosis (CVST), which was seen in combination with low levels of blood platelets (thrombocytopenia). All six cases occurred in women between the ages of 18...
Read More

NCCI Opioid Webinar

On September 19th, the National Council on Compensation Insurance (NCCI) hosted a webinar reviewing opioid prescribing patterns and the likelihood of continued opioid use among injured workers. Data presented came...
Read More

FDA Approves Pfizer COVID-19 Vaccine, Booster Shots on the Way

In late August, the FDA officially approved the Pfizer-BioNTech COVID-19 vaccine, which will officially be marketed as Comirnaty. This is the first FDA-approved vaccine for the prevention of COVID-19 and...
Read More

Certain Vancomycin, Phenylephrine, and Fentanyl IV Bags Recalled Due to Superpotency

Leiters Health is voluntarily recalling 33 lots of IV vancomycin, phenylephrine, and fentanyl products at the user level due to superpotency because the bags may contain twice the labeled amount...
Read More

Multiple Companies Recall Ranitidine Hydrochloride Due to Contamination

Back in September, Sandoz Inc. voluntarily recalled all quantities and lots within expiry of ranitidine hydrochloride capsules because of confirmed contamination with N-Nitrosodimethylamine (NDMA), a probable human carcinogen, above levels established by...
Read More

Teva Pharmaceuticals Recalls Specific Lots of Fentanyl Buccal Tablets CII

Teva Pharmaceuticals has voluntarily recalled specific lots of various strengths of fentanyl buccal tablets CII at the consumer level due to a labeling error. This recall has been initiated because...
Read More

DEA to Improve Access to Marijuana Research

...384 to 542, approximately 40%. Historically, research institutions have faced much difficulty completing the intensive, time-consuming application process to study marijuana that required cooperation with the DEA, the National Institute on Drug...
Read More
lockmap-markermagnifiercrossmenuarrow-rightcross-circle